Citius Oncology, Inc.

NasdaqCM: CTOR · Healthcare

Positivity Index

#1,774 / 6,774

Global

#439 / 4,000

United States

Positivity Score

22,318

Rank→

PosiRed: 1 active red flag (highest severity 6/10) View flag history →

PosiRed · red flag

Stock exchange listing-rule deficiency notice (8-K Item 3.01)

The company reported in a Form 8-K (Item 3.01) filed on 28 Apr 2026 that its stock exchange notified it of not meeting a continued-listing rule. Continued non-compliance can lead to delisting.

More details →

Citius Oncology, Inc. — Overview & Financial Snapshot

Citius Oncology, Inc. (NasdaqCM: CTOR) is a Healthcare company, ranked #1,774 of 6,774 companies globally and #439 of 4,000 in United States on PositoAI, with a Positivity Score of 22,318. Its market capitalisation is ₹698.29 Cr ($73.98M), P/E ratio is -1.5 and P/B ratio is 1.83. It currently has 1 active red flag (PosiRed) and no yellow flags (PosiYellow) on record.

For financial statements, ratio trends and score history, Go Deep →

What does Citius Oncology, Inc. do?

Citius Oncology, Inc. focuses on the development and commercialization of targeted oncology therapies. It also engages in the development of LYMPHIR, an orphan indication for the treatment of adult patients with relapsed or refractory cutaneous T-cell lymphoma, a rare form of non-Hodgkin lymphoma. The company is…

What is Citius Oncology, Inc.'s P/E and P/B ratio?

Citius Oncology, Inc. has a P/E ratio of -1.5 and a P/B ratio of 1.83.

What is Citius Oncology, Inc.'s debt-to-equity ratio?

Citius Oncology, Inc. has a debt-to-equity ratio of 0.25.

How much does Citius Oncology, Inc. owe compared with what it owns?

Citius Oncology, Inc. owes $0.64 for every $1 it owns (balance sheet Jun 2026), which is moderate.

What is Citius Oncology, Inc.'s Positivity rank?

Citius Oncology, Inc. is ranked #1,774 of 6,774 companies globally and #439 of 4,000 in United States on PositoAI, with a Positivity Score of 22,318.

Does Citius Oncology, Inc. have any regulatory orders, red flags (PosiRed) or yellow flags (PosiYellow)?

Yes. Citius Oncology, Inc. has 1 active red flag (PosiRed) on record: Stock exchange listing-rule deficiency notice (8-K Item 3.01) (dated 28 Apr 2026). It has no yellow flags.

Where can I read the latest news about Citius Oncology, Inc.?

Recent headlines about Citius Oncology, Inc. from the last 30 days, with links to the original articles, are on its News page on PositoAI.

Does Citius Oncology, Inc. have a PositoAI PosiShot or QR code?

Yes. A dated PosiShot of Citius Oncology, Inc.'s current position, a PosiQR code for its live profile and a ready-made dated mention are available on its For this company page on PositoAI.